title: Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy.
abstract: Parainfluenza virus (PIV) infection can be a problem among hematopoetic stem cell transplant recipients. 125 patients were prospectively evaluated for respiratory viral infections. We describe 5 patients with PIV 3 infection and their response to early treatment with ribavirin.
authors.affiliation: Department of Haematology, Birmingham Heartlands Hospital, Birmingham, United Kingdom.
authors.forename: S
authors.initials: S
authors.lastname: Chakrabarti
authors.forename: K E
authors.initials: KE
authors.lastname: Collingham
authors.forename: K
authors.initials: K
authors.lastname: Holder
authors.forename: S
authors.initials: S
authors.lastname: Oyaide
authors.forename: D
authors.initials: D
authors.lastname: Pillay
authors.forename: D W
authors.initials: DW
authors.lastname: Milligan
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010224:Parainfluenza Virus 3, Human; D011446:Prospective Studies; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000821:virology; D010253:Respirovirus Infections / Q000188:drug therapy* / Q000821:virology; D012254:Ribavirin / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin